Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms-Reference-Cited by-同舟云学术

Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms

Published:2023-07-17 Issue:14 Volume:7 Page:3637-3641
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Isabelle Colleen¹^ORCID,Johnson William T.²^ORCID,McConnell Kathleen¹^ORCID,Vogel Ashley³,Brammer Jonathan E.⁴,Boles Amy¹^ORCID,Keller Robyn¹,Sindaco Paola¹^ORCID,Nisenfeld Liam³,Uppal Guldeep³,Nikbakht Neda⁵^ORCID,Calabretta Bruno⁶,Porazzi Patrizia⁷⁸^ORCID,Gong Jerald³,Chakravarti Nitin¹^ORCID,Porcu Pierluigi¹^ORCID,Mishra Anjali¹⁶^ORCID

Affiliation:

1. 1Sidney Kimmel Cancer Center, Division of Hematologic Malignancies, Thomas Jefferson University, Philadelphia, PA

2. 2Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

3. 3Department of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA

4. 4Division of Hematology, Department of Internal Medicine, The James Comprehensive Center, The Ohio State University, Columbus, OH

5. 5Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA

6. 6Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

7. 7Division of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

8. 8Center for Cellular Immunotherapies, Division of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Publisher

American Society of Hematology

Subject

Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/7/14/3637/2065453/blooda_adv-2023-009807-main.pdf

Reference18 articles.

1. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes;Vose;J Clin Oncol,2008

2. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

3. Network NCC . T-Cell Lymphomas (Version 1.2020). 2020. https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf. Accessed 11 April 2023.

4. The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma;Horwitz;Ann Oncol,2022

5. Outcomes for relapsed and refractory peripheral T-Cell lymphoma patients after front-line therapy from the COMPLETE registry;Lansigan;Acta Haematol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53–p21 and p27 pathways;Scientific Reports;2024-04-23